| Literature DB >> 27553026 |
Meghan J Elliott1,2, Sharon E Straus3,4, Neesh Pannu5, Sofia B Ahmed6, Andreas Laupacis3,7,4, George C Chong8, David R Hillier9, Kate T Huffman10, Andrew C Lei11, Berlene V Villanueva12, Donna M Young13, Helen Tam-Tham14, Maoliosa Donald6, Erin Lillie3, Braden J Manns6,14, Brenda R Hemmelgarn6,14.
Abstract
BACKGROUND: Few studies have evaluated stakeholder engagement in chronic kidney disease (CKD) research prioritization. In this two-arm, parallel group randomized controlled trial, we sought to compare an in-person nominal group technique (NGT) approach with an online wiki-inspired alternative to determining the top 10 CKD research priorities, and to evaluate stakeholder engagement and satisfaction with each process.Entities:
Keywords: Chronic kidney disease; Patient preferences; Research priorities; Wiki
Mesh:
Year: 2016 PMID: 27553026 PMCID: PMC4995639 DOI: 10.1186/s12911-016-0351-y
Source DB: PubMed Journal: BMC Med Inform Decis Mak ISSN: 1472-6947 Impact factor: 2.796
Fig. 1Flow diagram outlining intervention group allocation and withdrawals. *Primary outcome measured at the group level
Baseline demographics of participants in the in-person workshop and online wiki groups, n (%)
| In-person workshop group ( | Patients and caregivers in in-person workshop ( | Online wiki-inspired group ( | Patients and caregivers in online wiki-inspired group ( | |
|---|---|---|---|---|
| Age | ||||
| 18–39 years | 3 (12) | 1 (5.6) | 4 (15.4) | 4 (21.1) |
| 40–64 years | 14 (56) | 9 (50) | 16 (61.5) | 9 (47.4) |
| ≥ 65 years | 8 (32) | 8 (44.4) | 6 (23.1) | 6 (31.6) |
| Sex | ||||
| Male | 13 (52) | 11 (61.1) | 11 (42.3) | 9 (47.4) |
| Female | 12 (48) | 7 (38.9) | 15 (57.7) | 10 (52.6) |
| Role | ||||
| Patient | 12 (48) | 12 (66.7) | 11 (42.3) | 11 (57.9) |
| Caregiver | 6 (24) | 6 (33.3) | 8 (30.8) | 8 (42.1) |
| Health Care Provider | 6 (24) | - | 6 (23.1) | - |
| Policymaker | 1 (4) | - | 1 (3.8) | - |
| Marital Status | ||||
| Married | 22 (88) | 16 (88.9) | 19 (73.1) | 13 (68.4) |
| Common Law | 1 (4) | 0 (0) | 2 (7.7) | 1 (5.3) |
| Divorced/Separated | 2 (8) | 2 (11.1) | 0 (0) | 0 (0) |
| Single | 0 (0) | 0 (0) | 3 (11.5) | 3 (15.8) |
| Not Indicated | 0 (0) | 0 (0) | 2 (7.7) | 2 (10.5) |
| Employment Status | ||||
| Full-time | 14 (56) | 8 (44.4) | 12 (46.2) | 6 (31.6) |
| Part-time or casual | 2 (8) | 1 (5.6) | 2 (7.7) | 1 (5.3) |
| Retired | 9 (36) | 9 (50) | 10 (38.5) | 10 (52.6) |
| Unemployed | 0 (0) | 0 (0) | 1 (3.8) | 1 (5.3) |
| Not Indicated | 0 (0) | 0 (0) | 1 (3.8) | 1 (5.3) |
| Highest Level of Education | ||||
| Some High School | 0 (0) | 0 (0) | 1 (3.8) | 1 (5.3) |
| High School Graduate | 4 (16) | 4 (22.2) | 3 (11.5) | 3 (15.8) |
| College Diploma | 4 (16) | 3 (16.7) | 8 (30.8) | 8 (42.1) |
| University Degree | 17 (68) | 11 (61.1) | 12 (46.2) | 5 (26.3) |
| Not Indicated | 0 (0) | 0 (0) | 2 (7.7) | 2 (10.5) |
Top 10 CKD-related research priorities resulting from the in-person workshop vs. online wiki-based groups
| In-person workshop group | Wiki rank | Online wiki-based group | Workshop rank |
|---|---|---|---|
| 1. What are the most effective new interventions and treatments to prevent the development and progression of kidney disease? | 1 | 1. What are the most effective new interventions and treatments to prevent the development and progression of kidney disease? | 1 |
| 2. What is the best diet to slow progression of kidney disease and what are the benefits and risks of specific diets (ie phosphate restriction, protein restriction, low salt etc.) in terms of kidney disease progression and quality of life? | 6 | 2. What are the harmful effects of medications used in patients with CKD, and in particular, the combinations of medications used to treat other diseases (such as diabetes and high blood pressure)? | 7 |
| 3. What are the causes of symptoms in patients with chronic kidney disease, including fatigue, low energy, sleeping problems, depression, anxiety and sexual dysfunction, and how can these best be treated to improve quality of life?a | 8 | 3. What are the best signs or markers (ie blood tests, urine tests or other tests) to identify and diagnose kidney disease early? | 14 |
| 4. What are the optimal strategies, such as having access to health information (eg lab test results), sharing of information, and/or improving communication, to help patients manage their health condition(s) themselves and to improve patient experience and outcomes? | Not ranked in the top 10 | 4. What are the benefits and risks associated with use of vitamins, supplements and alternative/complementary therapies (ie herbal, naturopathic, marijuana etc.) in terms of kidney disease progression and quality of life? | 11 |
| 5. What is the impact of lifestyle factors (ie exercise, stress) on risk of developing kidney disease, kidney disease progression, and quality of life? | 9 | 5. How can we predict how fast kidney function will get worse, and when kidneys will fail? | 13 |
| 6. What are the optimal strategies for the management of CKD (ie those undertaken by the primary care physician, nephrologist, other health care professionals) to delay progression and improve outcomes? | Not ranked in the top 10 | 6. What is the best diet to slow progression of kidney disease and what are the benefits and risks of specific diets (ie phosphate restriction, protein restriction, low salt etc.) in terms of kidney disease progression and quality of life? | 2 |
| 7. What are the harmful effects of medications used in patients with CKD, and in particular the combinations of medications used to treat other diseases (such as diabetes and high blood pressure)? | 2 | 7. What are the optimal medications (eg ACE inhibitors, ARBs, phosphate binders, sodium bicarbonate, etc.) to slow progression of kidney disease? | 19 |
| 8. What are the optimal approaches for the prevention and treatment of cardiovascular disease in patients with CKD? | Not ranked in the top 10 | 8. What are the causes of symptoms in patients with chronic kidney disease, including fatigue, low energy, sleeping problems, depression, anxiety and sexual dysfunction, and how can these best be treated to improve quality of life?a | 3 |
| 9. What is the best strategy (eg screening, programs targeting high risk groups, programs to increase public awareness) to identify kidney disease early? | Not ranked in the top 10 | 9. What is the impact of lifestyle factors (ie exercise, stress) on risk of developing kidney disease, kidney disease progression, and quality of life? | 5 |
| 10. How do we ensure that patients with CKD have equitable access to care (eg nephrologists, allied health clinics) irrespective of location of residence or socio-economic status? | Not ranked in the top 10 | 10. How can communication regarding patient care be improved and/or streamlined across all disciplines (primary care, nephrology, allied health) to improve outcomes and the patient experience? | 12 |
CKD chronic kidney disease, ACE angiotensin-converting enzyme, ARB angiotensin II receptor blockers
aItem subsumed a second uncertainty noted within the top 30 uncertainties in both the in-person and wiki groups
Fig. 2a Satisfaction of workshop and wiki participants on post-intervention questionnaire. *p < 0.05 for between-group difference. b Engagement of workshop and wiki participants on post-intervention questionnaire. *p < 0.05 for between-group difference
Main themes identified from written feedback on post-intervention questionnaire
| Group | Role | Comment |
|---|---|---|
| Limited Personal Interactions | ||
| Wiki | Caregiver | “It was easier not to put your whole heart into this as it would have been if it were done face to face with the other participants… I felt something was missing, some sort of connection with others facing the same difficulties.” |
| Wiki | Health Care Professional | “The wiki seemed to reward the last person to change the rankings. In person, a doc such as me could have had a more subtle way to influence the process without being aggressive or trying to take it over.” |
| Importance of Communication to Justify Selections | ||
| Wiki | Patient | “When people explained their rationale for their preferences, I understood. When the ranking was changed without using the chat feature to augment our understanding, I could not discern the rationale for the preferences.” |
| Wiki | Patient | “Although I enjoyed the discussions that did occur and the mix of group members (caregiver, patient, clinician), I'm not sure, as a whole, we really made the most of the chat feature.” |
| Wiki | Health Care Professional | “I think any changes in the top 10 should have had comments to support these changes.” |
| Wiki | Health Care Professional | “In a discussion forum online, I also didn't feel comfortable asking specific people to clarify or explain their choices.” |
| Format Effectiveness | ||
| Workshop | Caregiver | “The format enabled patients and caregivers to engage with a wide group of professionals, other than the traditional doctor-patient relationship.” |
| Wiki | Patient | “Basically, I felt this process was less effective and that we didn't actually reach a group consensus with our outcomes.” |
| Workshop | Patient | “The only part that was not entirely satisfactory was the final phase in which the entire group worked to re-order priorities. I felt that it lacked the fluidity and finesse to allow for minor changes.” |
| Perspectives Dependent on Participation | ||
| Wiki | Patient | “I was disappointed by the participation rate (those who did not participate). I think this affected the quality of the discussions and possibly weakened the final outcome.” |
| Workshop | Health Care Professional | “Some opinions/voices might not be represented depending on who attends (is able to attend) and who is approached to attend the workshop.” |
| Ability to Contribute Meaningfully | ||
| Workshop | Caregiver | “As a layperson I felt that even though I did not have the hard earned scientific expertise of the medical community, all our experiences were considered on their merits.” |
| Workshop | Patient | “The workshop was an amazing experience where a collaborative effort of all affected people by CKD joined together to come up with the top 10 important and highly timely research uncertainties that will give better life with the patients.” |
| Workshop | Patient | “I left feeling that in some small way I had contributed to research possibilities for my disease which currently has no cure.” |